Kimberley Biggs

Kimberley Biggs serves as a Postdoctoral Associate within the Department of Mechanical Engineering at the Massachusetts Institute of Technology (MIT), maintaining active research affiliations through the MIT MechE department despite her neuroscience-focused work.

Her primary research investigates peptide-based neurotherapeutics, utilizing in vitro evolution techniques to engineer cyclic peptide inhibitors targeting acid-sensing ion channels (ASIC1a) for stroke intervention. She concurrently explores venom-derived RF-amide peptides from caterpillars as modulators for epilepsy-related ion channels, bridging neuropharmacology, toxicology, and bioengineering.

Analysis of her 2020-2024 publications reveals a cohesive research program centered on venom biochemistry and directed peptide evolution, with consistent emphasis on stroke and epilepsy therapeutics development across neuroscience, pharmacology, and biochemical engineering disciplines.

Scientific Awards: No awards or honors are documented in the provided materials.

Advising and Grants: The available texts contain no information regarding graduate students mentored, grant funding, or collaborative projects.

Labs and Teams: While affiliated with MIT MechE, specific laboratory affiliations, research teams, or institutional partnerships are not specified in the source content.